University of Saskatchewan’s vaccine research team could start clinical trials in December or January.VIDO-Intervac is in the final stages before the COVID-19 vaccine they are developing will be tested on people.
After toxicology tests, Health Canada will need to approve the first two phases of clinical trials to ensure it is safe.“They’re also looking at some proof that the vaccine’s going to work,” said Dr.
Paul Hodgson, VIDO-InterVac associate director of business development. USask’s VIDO-InterVac team collaborating with other universities to develop COVID-19 vaccine VIDO-InterVac hasn’t just been busy developing a vaccine, it’s also working with over 80 different groups worldwide on other vaccines.American companies Moderna and.